发明授权
US07803809B2 Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
有权
取代的吡喃并[2,3-b]吡啶胺化合物作为β-分泌酶调节剂和使用方法
- 专利标题: Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
- 专利标题(中): 取代的吡喃并[2,3-b]吡啶胺化合物作为β-分泌酶调节剂和使用方法
-
申请号: US12291753申请日: 2008-11-12
-
公开(公告)号: US07803809B2公开(公告)日: 2010-09-28
- 发明人: Russell Graceffa , Matthew Kaller , Daniel La , Patricia Lopez , Vinod F. Patel , Wenge Zhong
- 申请人: Russell Graceffa , Matthew Kaller , Daniel La , Patricia Lopez , Vinod F. Patel , Wenge Zhong
- 申请人地址: US CA Thousand Oaks
- 专利权人: Amgen Inc.
- 当前专利权人: Amgen Inc.
- 当前专利权人地址: US CA Thousand Oaks
- 代理商 G. Prabhakar Reddy
- 主分类号: A61K31/44
- IPC分类号: A61K31/44
摘要:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I wherein R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Z are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits and impairment, schizophrenia and other similar central nervous system conditions. The invention also comprises further embodiments of Formula II, intermediates and processes useful for the preparation of compounds of Formulas I and II.
公开/授权文献
信息查询